Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03973931 · ClinicalTrials.gov registry record · NA
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications
A NA study of Hypertension and Cardiovascular Diseases, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 9,501
- Enrollment target
- 4
- Study locations
NCT03973931: Completed NA study of Hypertension and Cardiovascular Diseases, sponsored by University of Colorado, Denver.
NCT03973931 is a NA study of Hypertension and Cardiovascular Diseases that has completed, run by University of Colorado, Denver. The registered enrollment target is 9,501 participants, above the 3,487-participant average among 470 other Hypertension trials with a reported enrollment target (172% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03973931, a NA study of Hypertension and Cardiovascular Diseases, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 9,501 participants
- Enrollment target
- 4
- Study locations
Study Summary
The study plans to learn if sending different text messages, serving as reminders or encouragement, may help patients take their medication more often if they have had trouble keeping up with their medicines.
Primary Outcome
The primary outcome was medication adherence defined by the proportion of days covered (PDC) using pharmacy refill data adjusted difference from usual care.
Conditions Studied
Interventions
- BEHAVIORAL Nudge
Study Locations (4)
Colorado
- UCHealth - Aurora
- University of Colorado Denver - Aurora
- VA Eastern Colorado Health Care System - Aurora
- Denver Health and Hospital Authority - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,501 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2023-11-19 |
| Phase | NA |
What the finished NCT03973931 record still lists
NCT03973931 is an interventional study that assigns participants to a tested intervention. Its 9,501 participants enrollment target places it among the larger protocols in the corpus, above the 3,487-participant average among 470 other Hypertension trials with a reported enrollment target (172% higher).
The record links to 8 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Nudge is the first listed.
NCT03973931 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03973931 about?
NCT03973931 is a clinical study titled "Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications". The study plans to learn if sending different text messages, serving as reminders or encouragement, may help patients take their medication more often if they have had trouble keeping up with their medicines.
What is the current status of trial NCT03973931?
This trial is currently completed. It is a NA study. The enrollment target is 9,501 participants. The study started on 2019-07-01. Estimated completion is 2023-11-19.
What conditions does trial NCT03973931 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Coronary Artery Disease, Diabetes Mellitus, Atrial Fibrillation.
What interventions are being tested in trial NCT03973931?
The interventions under investigation include: Nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT03973931?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03973931 being conducted?
This trial has 4 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03973931's enrollment target sits among peer trials
9,501 22nd of 470 higher than 449 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI